These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6029404)

  • 21. Effect of thyrocalcitonin on urinary hydroxyproline and calcium in rats.
    Aer J
    Endocrinology; 1968 Aug; 83(2):379-80. PubMed ID: 5663493
    [No Abstract]   [Full Text] [Related]  

  • 22. The action of thyrocalcitonin in man: radiocalcium kinetics studies.
    Caniggia A; Gennari C; Bencini M; Palazzuoli V; Borrello G; Cesari L
    J Nucl Biol Med; 1969; 13(4):148-50. PubMed ID: 5400601
    [No Abstract]   [Full Text] [Related]  

  • 23. [Calcitonin sensitivity of old rats. Contribution on the pathophysiology of senility-osteoporoses].
    Holló I; Zombory J; Beregi E; Cseh G; Horváth F
    Z Alternsforsch; 1970; 23(1):71-6. PubMed ID: 5480606
    [No Abstract]   [Full Text] [Related]  

  • 24. [Induced tooth movement and thyrocalcitonin].
    Klingler E
    Orthod Fr; 1974; 45(2):119-29. PubMed ID: 4534496
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative effects of phosphate and thyrocalcitonin on skeletal turnover.
    Haddad JG; Avioli LV
    Endocrinology; 1970 Dec; 87(6):1245-50. PubMed ID: 5482702
    [No Abstract]   [Full Text] [Related]  

  • 26. On the mode of the hypocalcemic action of thyrocalcitonin and its enhancement by phosphate in rats.
    Hirsch PF; Sliwowski A; Orimo H; Darago LS; Mewborn QA
    Endocrinology; 1973 Jul; 93(1):12-9. PubMed ID: 4712247
    [No Abstract]   [Full Text] [Related]  

  • 27. Thyrocalcitonin inhibition of bone resorption induced by parathyroid extract in thyroparathyroidectomized rats.
    Hirsch PF
    Endocrinology; 1967 Mar; 80(3):539-41. PubMed ID: 6020221
    [No Abstract]   [Full Text] [Related]  

  • 28. Absorption, deposition and excretion of Sr89 by the chick in relation to route of administration.
    Creger CR; Colvin LB; Couch JR
    Proc Soc Exp Biol Med; 1967 Feb; 124(2):445-8. PubMed ID: 6019878
    [No Abstract]   [Full Text] [Related]  

  • 29. Extraction, partial purification and demonstration of biological activity of human thyrocalcitonin.
    Barrett RJ; Bell NH; Stern PH; Schlueter RJ
    J Clin Endocrinol Metab; 1968 May; 28(5):734-9. PubMed ID: 5653206
    [No Abstract]   [Full Text] [Related]  

  • 30. Mode of action of thyrocalcitonin.
    Robinson CJ; Martin TJ; Matthews EW; MacIntyre I
    J Endocrinol; 1967 Sep; 39(1):71-9. PubMed ID: 6050965
    [No Abstract]   [Full Text] [Related]  

  • 31. [Recent advances on the thyrocalcitonin].
    Milhaud G
    Ann Endocrinol (Paris); 1968; 29(5):563-75. PubMed ID: 4881133
    [No Abstract]   [Full Text] [Related]  

  • 32. Species discrimination between calcitonins.
    Parsons JA; Reynolds JJ
    Lancet; 1968 May; 1(7551):1067-70. PubMed ID: 4171748
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of thyrocalcitonin in neonatal animals.
    Phillippo M; Care AD; Hinde FR
    J Endocrinol; 1969 Jan; 43(1):xv-xvi. PubMed ID: 5789236
    [No Abstract]   [Full Text] [Related]  

  • 34. [Calcitonin. Effects on cartilage and bone grafts].
    Esposito A; Lanzetta A
    Nouv Presse Med; 1972 Jul; 1(27):1847-50. PubMed ID: 4261227
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypocalcemia response following calcitonin administration: lack of correlation with osteoclast number determined after histoenzymologic identification in osteoporosis.
    Palle S; Chappard D; Vico L; Alexandre C
    Clin Rheumatol; 1988 Sep; 7(3):354-8. PubMed ID: 3229081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyrophosphate enhancement of thyrocalcitonin effect in tissue culture.
    Orimo H; Fujita T; Yoshikawa M
    Endocrinol Jpn; 1969 Aug; 16(4):415-21. PubMed ID: 4312273
    [No Abstract]   [Full Text] [Related]  

  • 37. [Role of thyrocalcitonin in osteogenesis].
    Briskin AI
    Ortop Travmatol Protez; 1973 Dec; 34(12):69-71. PubMed ID: 4790654
    [No Abstract]   [Full Text] [Related]  

  • 38. Thyrocalcitonin suppression of hydroxyproline rlease from bone.
    Klein DC; Talmage RV
    Proc Soc Exp Biol Med; 1968 Jan; 127(1):95-9. PubMed ID: 5644673
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of bone resorption by acetazolamide in the rat.
    Waite LC; Volkert WA; Kenny AD
    Endocrinology; 1970 Dec; 87(6):1129-39. PubMed ID: 4320594
    [No Abstract]   [Full Text] [Related]  

  • 40. Importance of endogenous thyrocalcitonin for protection against hypercalcemia in the rat.
    Cooper CW; Hirsch PF; Munson PL
    Endocrinology; 1970 Feb; 86(2):406-15. PubMed ID: 5409935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.